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Abstract 
 
Cherubism (CBM) is characterized by multiple fibro-osseous lesions in jawbones and 
caused by mutations in the SH3-domain binding protein 2 (SH3BP2). CBM patients also suffer 
from dental abnormalities. Biochemical analyses showed that mutations in CBM lead to SH3BP2 
gain-of-function because mutant SH3BP2 is protected from tankyrase-mediated proteasomal 
degradation. A knock-in (KI) mouse model expressing a CBM substitution mutation (P416R) in 
Sh3bp2 has been generated. Homozygous mice (Sh3bp2KI/KI) show increased systemic 
inflammation and osteopenia phenotype with high serum TNF-α level, increased numbers of 
macrophages and enhanced osteoclastogenesis. Heterozygous mice (Sh3bp2+/KI) exhibit 
intermediate phenotype with increased bone resorption without significant elevation of TNF-α. 
Here, we utilized CBM mice to study whether CBM-causing SH3BP2 mutant protein potentiates 
the development of apical periodontitis. Sh3bp2+/+, Sh3bp2+/KI and Sh3bp2KI/KI male and female 
mice (8 week-old) were analyzed 3, 7, 14 and 21 days after pulp exposure of the right mandibular 
first molars. Left molars from the same mice without pulp exposure were used as controls. While 
Sh3bp2+/+ and Sh3bp2+/KI mice recovered after initial significant weight loss for 7 days, Sh3bp2KI/KI 
mice continued to lose weight through 21 days after pulp exposure. Sh3bp2KI/KI mice without 
receiving dental procedures did not have significant weight loss suggesting the weight loss is 
caused by the development of apical periodontitis. Radiographs by Faxitron and micro-CT showed 
1) periapical bone destruction can be observed as early as day 3 in Sh3bp2KI/KI mice; 2) 
significantly increased bone destruction in Sh3bp2KI/KI mice; 3) Sh3bp2+/KI mice exhibited 
intermediate sizes of apical lesions. H&E staining of paraffin sections showed the most severe 
periapical inflammatory bone loss in Sh3bp2KI/KI mice. Sh3bp2KI/KI mice showed significantly 
higher percentage of cathepsin K-positive (+) area normalized to the bone perimeter on days 7 and 
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14 compared to other groups. Our study suggests that Sh3bp2 gain-of-function in CBM potentiates 
the development of apical periodontitis. Increased bony destruction associated with apical 
periodontitis may occur in CBM patients thus close monitoring the oral health of CBM patients is 
recommended as part of standard care.  
 1 
Chapter I: Introduction 
 
Cherubism 
Introduction of cherubism (CBM) 
In 1933, William A. Jones defined “cherubism” as “familial multilocular cystic disease of 
the jaws” due to the similarity of the classical characteristics of full round cheeks and upward cast 
of the eyes to the angelic look of the cherubs immortalized by Renaissance art (Figure 1) (1, 2). 
Phenotypically, CBM is characterized by bilateral expansion of the jaws with fibrous tissue 
deposition (1, 3-7). The pathological facial changes appear 2–5 years after birth with initial rapid 
enlargement of the jaws and regress after puberty. It affects males and females and has been 
reported in patients of all racial and ethnic backgrounds (8). CBM is a rare bone disorder that is 
inherited as autosomal dominant form and mutations responsible for CBM have been identified in 
the SH3BP2 gene. The SH3BP2 adapter protein is required for optimal B-cell activation, thymus-
independent type 2 humoral response and chemoattractant-mediated neutrophil activation (8-10).  
 
 
Figure 1. A: Individual with CBM at age 12. The facial swelling in this severe case affects the upper and lower 
jaws. B: Computed tomography three-dimensional image shows excessive bone degradation and replacement by 
soft tissue masses. (3) C: Cone beam computed tomography examination scan from a CBM patient at age of 15 
with osteosclerosis (2) 
A B C
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Clinical diagnosis of CBM is based on the facial features, dental abnormalities and genetic 
test to identify mutations in SH3BP2 gene (11). However, some CBM patients may not have 
mutations in SH3BP2. Mild forms of CBM may not require treatment because CBM often 
regresses spontaneously after puberty with yet unknown mechanisms. Therefore, treatment of 
CBM depends on the natural course of the disease and the clinical behavior of each case (8). 
Longitudinal observation in these cases are recommended until functional or emotional 
disturbances demand surgical intervention. Treatment of CBM consists of conservative oral care, 
local curettage of the lesions, jaw contouring, intralesional steroid injections, radiation, interferon, 
and systemic calcitonin administration (1, 12). Abnormal inflammatory responses are the main 
component of the pathophysiology of CBM. It has been reported that that high levels of tumor 
necrosis factor (TNF-α) in the circulating blood system contribute to the progression of CBM (4). 
A possible therapy to reduce TNF-α levels could be TNF-α blocker (5). Disappointedly, the anti-
TNF treatment only showed no to mild amelioration of CBM. Yoshitaka et al. demonstrated that 
bone marrow transplant improves the inflammation and bone loss (13). More recently, SYK 
inhibitor, Entospletinib, has been shown to ameliorate inflammation and bone destruction in the 
Sh3bp2KI/KI male (14). SYK inhibitor has not been tested in CBM patients. Future potential 
therapeutics could be related to molecular mechanisms for the action of mutant SH3BP2 such as 
nuclear factor of activated T cells c1 (NFATc1) which regulates osteoclast gene expression (8).  
Dental abnormalities of CBM 
CBM affects tooth development and eruption of the primary and permanent dentition (15). 
Dental findings of CBM include: missing teeth, malocclusion, root resorption, and premature 
exfoliation of deciduous teeth.  Bilateral, multilocular, expansile radiolucencies with cortical 
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thinning and destruction in the ramus, angulus and corpus of both sides of the mandible are the 
radiographic features of CBM. The problem of early loss of deciduous teeth, delayed development, 
or eruption of the permanent teeth is difficult to treat and no satisfactory solution is available. 
Histological findings resemble giant cell granulomas, which contain fibrous tissue and osteoclast-
like giant cells (Figure 2) (5). Numerous small vessels with large endothelial cells and perivascular 
capillary cuffing are also present. Tooth extraction may be needed if teeth are “free-floating” in 
CBM lesions, or if they become ectopically impacted. Children may require prostheses that are 
adjusted as the child grows. Orthodontic treatment is appropriate after growth is completed and 
when CBM is regressing (5, 8). All CBM patients included in a cohort study have either partial or 
complete dentures (16). Therefore, dental abnormalities can bring enormous emotional and social 
disturbances to CBM patients.  
 
Mouse model for CBM 
Genetic mutation responsible for CBM was first mapped to chromosome 4p16.3 and later 
identified in SH3BP2 gene (3). It has been shown that CBM mutations in SH3BP2 lead to loss of 
Tankyrase-mediated protein degradation leading to excessive expression of SH3BP2 (17). Two 
CBM knock-in mouse models have been generated by introducing CBM mutations (P416R or 
G418R) in Sh3bp2 (4, 18). Both mouse models showed autoinflammatory lesions and osteopenia 
Figure 2(A): Intraoral view shows missing teeth, malocclusion and swelling of the alveolar ridges. (1, 2) (B): Panoramic 
radiograph shows bilateral well-defined multilocular radiolucent lesions in jawbones. (5)  (C): Multinucleated giant cells are 
scattered in vascular fibrous stroma with osteoid and newly formed bone matrix.(1)  
 
A C
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phenotype. Several mechanisms may account for these phenotypes in CBM mice: 1) Inflammatory 
reactions caused by increased macrophage numbers with high serum TNF-α level and 2) bone 
resorption caused by hyperactive osteoclasts via hyperactive SYK, SRC, VAV signaling and 
increased NFATc1. SH3BP2 protein plays important roles in many types of immune cells. In 
mouse models with ablated SH3BP2 genes there is a perturbation in the peritoneal B1 and splenic 
marginal-zone B-cell compartments suggesting SH3BP2 is required for optimal B-cell activation 
(10). CBM mutant SH3BP2 protein enhanced B-cell receptor signaling (19). In Sh3bp2KI/KI mice, 
it was found that inflammatory lesions develop independently of B- or T-cell involvement (4). 
Yoshitaka et al. demonstrated that the inflammation in CBM mice was rescued in the absence of 
Toll-like receptors (TLRs) 2 and 4 (20). Mutant macrophages are hyper-responsive to pathogen-
associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) that 
activate TLRs resulting in TNF-α over-production. The presence of a large amount of TLR ligands, 
oral bacteria and DAMPs during jawbone remodeling, may cause the jaw-specific development of 
human CBM lesions. Reduced levels of DAMPs after stabilization of jaw remodeling may 
contribute to the age-dependent regression (20). 
To date, it has never been studied whether CBM patients respond to bacteria challenges 
leading to apical periodontitis (AP) differently when compared to healthy subjects. Our study uses 
a knock-in mouse model expressing the most common mutation identified in CBM, P416R 
(proline-to-arginine substitution) (4). Both Sh3bp2+/KI and Sh3bp2KI/KI mice have osteopenia 
phenotype caused by increased bone resorption (Figure 3). Furthermore, Sh3bp2KI/KI mice also 
have increased serum TNF-α levels which is a pro-inflammatory cytokine [1]. We aim to examine 
how AP develop differently in Sh3bp2+/+, Sh3bp2+/KI and Sh3bp2KI/KI mice.  
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Apical periodontitis 
Etiology 
The etiology, pathogenesis, and histopathology of AP are very similar to that of marginal 
periodontitis. Both diseases are caused by bacterial infection and involve pathologic changes of 
alveolar bone, periodontal ligament, and cementum. Marginal periodontitis affects coronal 
periodontal tissues, whereas AP affects apical periodontal tissues. Bone loss is one of characteristic 
features in both diseases: crestal bone is lost in marginal periodontitis, and apical bone undergoes 
resorption in AP. AP can be caused by both exogenous and endogenous factors. Exogenous factors 
include microbes and their toxins and noxious metabolic byproducts, chemical agents, mechanical 
irritation, foreign bodies, and trauma. Endogenous factors include the host’s metabolic products, 
Figure 3. MicroCT images of (A) cross sections through 1st molar furcation showing incisors; (B) reconstructed three-
dimensional mandibles of Sh3bp2+/+, Sh3bp2+/KI and Sh3bp2KI/KI male littermates. Arrows indicate abnormal pits on 
mandibular surface. (C) Three-dimensional microCT images of metaphyseal trabecular bones in Sh3bp2+/+, Sh3bp2+/KI 
and Sh3bp2KI/KI male littermates. (4) 
A
B
C
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such as urate and cholesterol crystals, as well as cytokines or other inflammatory mediators. Both 
factors induce immune-inflammatory responses (21). 
However, infection of the pulp tissue caused by caries or other pathways is the primary 
cause of AP (22, 23). The outcome of pulpal insult is a dynamic process and it depends on the 
invading microorganisms and host responses (24, 25). The role of microorganisms is discussed in 
the next section.  
Based on the patient’s symptoms and the radiographic presentation, AP can be 
symptomatic (SAP) or asymptomatic (AAP) (26-28). Clinical features of SAP include a painful 
response to biting and/or percussion or palpation. SAP can also result in severe spontaneous, 
throbbing, and occasionally radiating pain to neck or head. It might or might not be associated 
with a periapical radiolucency area, and radiographs may show a widened periodontal ligament. 
Histologically, polymorphonuclear leukocytes and macrophages, and possibly, liquefaction 
necrosis in small areas of the pulp are observed (28). AAP does not produce clinical symptoms 
and has an unremarkable response to percussion or palpation. Radiographic images may show a 
break in the lamina dura to a large periapical radiolucency, and histologic images would be 
consistent with a periapical granuloma or an apical cyst (27).  
Microorganisms   
Bacteria 
 
Bacteria are considered the primary cause of AP which most part arise from the normal 
oral microbiota under predisposing conditions (29-31). Although more than 500 different bacteria 
species have been identified in association with endodontic infections using different culture and 
molecular methods, 20-40 of them are more frequently involved in AP (32-34). From the literature, 
it is evident that there is no single named species involved in disease etiology when bacterial 
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community profiles are considered, meaning that associations of any specific species with AP is 
rarely. However, any species found in the canal may play a role in the pathology and ecology of 
the microbial community (32). It has been shown that the severity of pulpal/periapical 
inflammation has been directly correlated with the total microbial content within root canals, and 
with the length of time the periapical tissues were exposed to the infecting microorganisms (35). 
In the advanced stage of the infectious process, bacteria are characterized by a mixed community 
arranged in biofilms (29, 30). Therefore, AP can be considered a human infection disease caused 
by bacteria biofilms in the root canal, which release products that accumulate in the periradicular 
tissues giving rise to an inflammatory response that may lead to destruction of the periodontal 
ligament and bone (30, 32). 
Several studies have tried to correlate some bacterial species with SAP or AAP, but the 
same species can also be found in both cases (31, 36-39). Anaerobic bacteria are dominated in 
primary infection with an overall bacteria density of 103 to 108, and the time of infection can 
influence this dominance increasing the level of bacteria at late stages of infection (40-45). 
Bacterial species frequently detected in SAP and AAP belong to diverse genera of gram-negative 
(i.e. Fusobacterium, Porphyromonas, Prevotella, Dialister, Tannerella, Treponema, 
Campylobacter, and Veillonella) and gram-positive (i.e. Actinomyces, Peptostreptococcus, 
Parvimonas, Filifactor, Pseudoramibacter, Olsenella, Streptococcus, Propionibacterium, and 
Eubacterium) (31, 34, 38, 46-50). In terms of amounts of bacteria, SAP cases showed higher levels 
than AAP cases (32, 34, 38, 47). The purpose of endodontic treatment of AP is to eliminate the 
infection in root canal system and relief patients’ symptoms. After root canal treatment, the level 
of bacteria decreases to 102-105 per sample, and gram-negative bacteria are less common to be 
found than gram-positive bacteria (41, 51-58). In secondary infection, adequate endodontic root 
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canal treatment may contain 15 species, whereas, inadequate treatment may reach up to 30 species 
(59-62). In teeth with persistent infection, the bacterial density increases to 103-107 cells (42, 54, 
63).  
The role of specific mixture of bacteria in association with AAP and SAP is still unclear. 
The inconsistency in terms of bacteria species prevalence in AAP and SAP cases can be explained 
by the following factors: sampling technique, sensitivity of the identification method, geographic 
location, patient’s age, accuracy or divergence in clinical diagnosis, disease classification, 
differences in virulence among strains of the same species, bacterial interactions among species in 
mixed communities, bacterial population density, incomplete root canal treatment, host resistance, 
environmental factors, and genetic patterns (32, 49, 64, 65).  Another important consideration is 
uncultivated bacteria which may play a role in AAP and SAP. With molecular methods exhibiting 
a higher resolution to disclose the diversity and complexity of most endogenous infections, more 
complex bacterial interactions have been found in AP (66). Table 1 shows the summary of the 
occurrence of bacteria in AP based on the studies.  
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Table 1- Occurrence of bacteria in symptomatic (SAP) and asymptomatic (AAP) apical periodontitis.  
SAP AAP Results Ref 
D. invisus, P. 
endodontalis, S. moorei, 
P. acnes, and 
Streptococcus sp. 
D. invisus, F. nucleatum, and 
P. endodontalis. 
Species formed different partnerships and 
associations in samples from teeth with or without 
pain. The most prevalent bacteria in SAP cases were 
D. invisus, P. endodontalis, S. moorei, 
Propionibacterium acnes, and Streptococcus species. 
(31) 
F. nucleatum sp, 
Veillonella parvula, 
Treponema socranskii, 
Tannerella forsythia, 
Enterococcus faecalis, 
and Campylobacter 
gracilis…  
F. nucleatum sp., E. faecalis, 
Eubacterium saburreum, and 
Neisseria mucosa, 
Peptostreptococcus 
micros... 
Significant difference was observed in the total levels 
of bacteria in SAP and AAP cases. Association was 
found between higher total bacterial counts and levels 
of T. forsythia and the presence of pain. 
Propionibacterium acnes were reduced in 
symptomatic cases. 
(38) 
Fusobacterium sp., 
Peptostreptococcus 
micros, Porphyromonas 
gingivalis, Treponema 
socranskii, B. forsythus, 
Prevotella nigrescens. 
Fusobacterium sp., 
Peptostreptococcus micros, 
Porphyromonas gingivalis, 
Treponema socranskii, B. 
forsythus. Prevotella 
nigrescens. 
Higher level of bacteria was observed in SAP than 
AAP cases. Significant relationships were shown in 
the combination of B. forsythus/P. gingivalis and 
Treponema sp./ P. gingivalis. There was no 
significant association between any bacteria and any 
symptoms. 
(34) 
Filifactor alocis, 
Treponema denticola, 
Tannerella forsythia. 
Filifactor alocis, Treponema 
denticola, Tannerella 
forsythia. 
F. alocis, T. forsythia, and T. denticola were 
associated with endodontic signs and symptoms. F. 
alocis and T. forsythia were detected more frequently 
in teeth with necrotic pulp than in teeth with failing 
endodontic treatment. 
(46) 
F. necrophorum, P. 
prevotii, P. micros, S. 
sanguis, F nucleatum, P. 
intermedia. G. 
morbillorum, Veillonella 
spp… 
F. necrophorum, P. prevotii, 
P. micros, S. sanguis, F 
nucleatum, P. intermedia. G. 
morbillorum, Veillonella 
spp… 
Higher level of bacteria was observed in SAP than 
AAP cases. Associations were found between 
spontaneous pain and Prevotella spp. and Bacteroides 
spp. Tenderness to percussion was related to 
Bifidobacterium spp., Actinomyces spp. and S. 
constellatus.  
(47) 
P. intermedia, P. 
gingivalis, P. 
endodontalis, P. micros, 
Enterococcus sp., 
Streptococcus sp., F. 
nucleatum…  
P. intermedia, P. gingivalis, 
P. micros, Enterococcus sp., 
Streptococcus sp., F. 
nucleatum, T. forsythensis, T. 
denticola, …  
T. denticola, D. invisus, Olsenella uli and Synergistes 
sp. were detected in the asymptomatic but not the 
symptomatic patient. P. endodontalis was found in 
SAP but not in AAP. All other species except 
enterococci were detected.  
(48) 
Campylobacter genus, 
Enterobacteriaceae genus, 
Fusobacterium genus, 
Leptotrichia genus, 
Filifactor alocis,  
Campylobacter genus, 
Enterobacteriaceae genus, 
Acinetobacter genus,  
Photorhabdus luminescens, 
Similarities to species of the Campylobacter genus, 
and Enterobacteriaceae genus found in AAP and SAP 
cases; Fusobacterium genus in SAP cases; 
Acinetobacter genus in AAP cases. Significant 
differences in the predominant bacterial composition 
between AAP and SAP cases were observed. 
(49) 
Fusobacterium sp., 
Peptostreptococcus sp, 
Prevotella sp., 
Mogibacterium sp, 
Lachnospiraceae sp., 
Filifactor alocis, …  
Fusobacterium sp., 
Peptostreptococcus sp, 
Prevotella sp., Mogibacterium 
sp, Lachnospiraceae sp., 
Filifactor alocis,...  
Bacteroides sp. and Dialister sp. were detected only 
in AAP cases. F. nucleatum, P. intermedia, D. 
pneumosintes, Prevotella sp and some phylotypes 
were exclusively detected in SAP cases. The 
structure of the microbiota differs significantly 
between AAP and SAP infections. 
(50) 
Enterococcus faecalis Enterococcus faecalis E. faecalis was significantly more associated with 
AAP than with SAP cases, and was much more likely 
(67) 
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to be found in cases of failed endodontic therapy than 
in primary infections. 
T. denticola, T. forsythia 
and P. gingivalis.  
T. denticola, T. forsythia and 
P. gingivalis. 
Bacteria were mostly associated with SAP, and only 
sporadically detected in patients with AAP. 
(68) 
Porphyromonas gingivalis Porphyromonas gingivalis P. gingivalis was found in 44.5% of specimens with 
symptoms. Types II (69.4%) were the most frequent 
in the SAP cases followed by type IV (32.7%). The 
occurrence of type I (64.3%) was significantly higher 
in AAP.  
(69) 
Enterococcus faecalis, 
Candida albicans and 
Porphyromonas 
gingivalis… 
Enterococcus faecalis, 
Candida albicans and 
Porphyromonas gingivalis… 
Association were found between SAP and 
combination Prevotella spp., Treponema spp., 
Peptostreptococcaceae sp. HOT-113, Olsenella uli, 
Slackia exigua, Selemonas infelix, P. gingivalis.  
(70) 
Eubacterium sp, 
Bacteroides sp, 
Peptostreptococcus sp., 
Streptococcus sp.  
Streptococci sp, 
Peptostreptococcus sp, 
Actinomyces sp.  
Bacteroides and P. magnus were more frequently 
detected in SAP cases, while Streptococci and 
Enteric bacteria in AAP cases.  
(71) 
Bacteroides 
melaninogenicus 
Bacteroides melaninogenicus B. melaninogenicus was found to be significantly 
related to pain, sinus tract formation. 
(72) 
Firmicutes, 
Proteobacteria, 
Actinobacteria, 
Bacteroidetes and 
Fusobacteria… 
Firmicutes, Proteobacteria, 
Actinobacteria, Bacteroidetes 
and Fusobacteria… 
SAP patients had more Firmicutes and Fusobacteria 
than AAP patients, while AAP patients showed more 
Proteobacteria and Actinobacteria. The comparison 
of SAP and AAP patients showed a clear association 
of the composition of the bacterial community with 
the presence and absence of symptoms in conjunction 
with the patients’ age 
(64) 
P. micros, F. 
necrophorum, F. 
nucleatum, P. 
intermedia/nigrescens, P. 
gingivalis, and P. 
endodontalis. 
 Relationships were found between anaerobes, 
especially gram-negatives, and the presence or 
history of pain, tenderness to percussion and 
swelling. Associations were found between SAP and 
P. micros, P. intermedia/nigrescens and Eubacterium 
spp.  
(73) 
Red complex: B. 
forsythus, P. gingivalis, 
and T. denticola 
 No particular signs or symptoms were associated 
with the presence of these red complex bacterial 
species. 
(74) 
E. faecalis, P. gingivalis, 
P. intermedia, T. 
forsythensis, T. denticola 
 T. denticola was detected in teeth with SAP in the 
presence of apical bone resorption. E. faecalis was 
associated with treatment failures.  
(75) 
P. gingivalis, T. denticola, 
and T. forsythia 
 P gingivalis, T denticola, and T forsythia were 
detected in 46%, 38%, and 22% of SAP cases, with 
spontaneous pain, tenderness to percussion, swelling, 
and pain on palpation.  
(76) 
Prevotella spp, 
Fusobaterium spp, 
Peptostreptococcus spp, 
Enterococcus spp… 
 Significant associations between pain or history of 
pain and polymicrobial infections or anaerobes in 
root-filled teeth SAP. 
(62) 
Bacteria and archaea  Bacteria were detected in 93% of root canal samples, 
and archaea in 38%. The incidence of SAP cases 
positive for both bacteria and archaea (73%) were 
significantly higher than those positive for bacteria 
alone (45%). 
(77) 
F. nucleatum, B. 
intermedius, P. 
anaerobius, P. micros, 
Lactobacillus sp., E. 
 77% of root canals containing black-pigmented 
Bacteroides species were associated with acute apical 
abscesses and purulent drainage through the root 
canal. 25% of teeth with black-pigmented 
Bacteroides were asymptomatic. 
(78) 
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lentum, E. alactolyticum, 
Bacteroides sp… 
B. forsythus, P. gingivalis, 
S. constellatus, P. 
intermedia, P. nigrescens 
… 
 The results suggest that acute periradicular abscesses 
is polymicrobial and are the main cause of pain and 
swelling. 
(79) 
Actinomyces, 
Lactobacillus, black-
pigmented Bacteroides, 
Peptostreptococcus,  
 Of the 50 bacterial isolates, 34 (68%) were strict 
anaerobes. This study demonstrates the presence of 
predominantly anaerobic bacteria in the apical 5 mm 
of infected root canals in SAP teeth. 
(45) 
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Fungi 
 
Fungi are eukaryotic microorganisms that can be found in endodontic infections and 
participate in the etiology of periradicular diseases (80, 81). They possess virulence attributes such 
as adaptability and adhesion to several environmental conditions, the production of hydrolytic 
enzymes, morphologic transition, biofilm formation, evasion and immunomodulation of the host 
defense (80, 82). Fungi have occasionally been found in AP with primary infections, but they 
appear to occur more often in the treated root canals in which treatment has failed (54, 60-62, 83, 
84). The most important oral fungi are the family of Candida. Candida albicans is the most 
commonly species isolated from infected root canals, and it is known as dentinophilic 
microorganism because of its invasive affinity to dentin (80, 81). Egan et al. reported that C. 
albicans was more frequent in root canal-treated teeth (6.7%) than non-treated teeth (3.3%) with 
AP (85). In another study, C. albicans was found in 9% of symptomatic root canal treated teeth 
with persistent periradicular lesions, confirming that it takes part in the microbiota associated with 
failed endodontic therapy (60). C. albicans was found in association with Streptococcus spp in 
unsealed teeth (62).  Dumani et al. showed that C. albicans and E. faecalis were associated with 
AP in primary and secondary infections (86). C. albicans was found in 36% of patients with 
periapical lesions and 13% in patients without periapical lesions, suggesting that the elimination 
of this microorganism from the root canal system, using appropriate intracanal solutions and 
medications is of utmost importance (87). In another study, it was investigated the prevalence of 
E. faecalis and C. albicans in the root filled teeth associated with SAP. The result showed that E. 
faecalis was found to be prevalent species, detected in 65% of the cases and C. albicans was 
detected in 35% of cases. The authors suggest that geographical influence and dietary factors might 
have some role to play in the prevalence of the species like C. albicans and presence of E. faecalis 
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(88). Machado et al. reported a higher Candida adherence of samples isolated from patients with 
AP (89). 
Viruses  
 
Herpesvirus, including human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) and 
herpes simplex virus (HSV), have been detected in AP samples  (90-95). It is proposed that 
herpesviruses may increase the virulence of resident bacterial pathogens by enhancing bacterial 
adherence and invasiveness (90, 91). In AP, the destruction of mammalian cells by herpesvirus 
infection may facilitate the penetration of bacteria into connective tissue. Herpesvirus can inhibit 
the expression of macrophage surface receptors that recognize components in the gram-negative 
bacterial cell wall and prevent macrophages from destroying invasive bacteria (95, 96).  
Table 2 shows the occurrence of herpesvirus infection in SAP and AAP and summaries of 
the results. Most of the studies detected HCMV and EBV in more than 50% of SAP cases and it 
was less detected in AAP cases (92, 93, 95, 97-103). In terms of coinfection, three studies detected 
HCMV/EBV in more than 50% of SAP cases and it was less detected AAP cases (95, 100, 103). 
Six studies reported coinfection of HCMV/EBV in less than 50% of SAP cases (93, 99, 101, 102, 
104-106). Such discrepancies in the detection rates of HCMV and EBV in reported studies might 
be attributed to different factors such as clinical status of the study subjects, viral diagnostic 
methods used, geographic differences in herpes viral occurrence, presence of the viruses in latently 
infected cells, different subtypes of EBV and HCMV (90, 94, 99, 107).  
Herpesviruses may cause AP as a direct result of virus infection and replication which may 
damage the host defense (91). The possibility that the bacterial infection process activates the 
viruses has been proposed (107). It is hypothesized that AP may develop as a result of a series of 
interactions among herpesviruses, bacteria, and host immune reactions (91). Indeed, SAP cases 
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infected with EBV were more likely to be infected with Treponema denticola, Prevotella 
intermedia, Aggregatibacter actinomycetemcomitans, and Porphyromonas gingivalis (104). 
Sabeti et al. reported that herpesvirus species in cooperation with bacteria may play major roles in 
SAP in humans (95). SAP was likely to occur in large-sized AP lesions than small lesions when 
infected with EBV or HCMV and EBV (93, 97). The interactions between herpesvirus and bacteria 
may explain the clinical symptoms of AP (103). For example, the absence of herpesvirus infection 
or reactivation and the lack of pathogenic bacteria may explain the fact that some teeth with AP 
can maintain periapical health or minimal disease for extended periods of time (91, 103). 
Therefore, to prevent and treat AP a possible solution maybe the use of antiviral agents (sodium 
hypochlorite and iodine) and vaccination against herpesviruses (91). 
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Table 2 – Occurrence of virus infections in symptomatic (SAP) and asymptomatic (AAP) apical periodontitis: Epstein-Barr virus 
(EBV), herpes simplex virus (HSV-1), human herpesvirus (HHV), and Varicella zoster virus (VZV). 
SAP AAP Results Ref 
HCMV (71%), EBV 
(42%), coinfection 
HCMV/EBV (35.5%) 
HCMV (24%), EBV 
(0%), coinfection 
HCMV/EBV (0%) 
Symptomatic manifestation was likely to 
occur if a large-sized AP lesion is aggravated 
with active EBV infection.  
(93) 
HCMV (100%) and 
EBV (80%) 
HCMV (14%) and EBV 
(14%) 
HCMV and EBV virus mRNA were mostly 
detected in SAP than AAP. (92) 
HCMV (15%), EBV 
(43%), HSV-1 (15%), 
VZV (0) 
HCMV (16%), EBV 
(45%), HSV-1 (9.68%), 
VZV (0) 
No significant differences in the incidence of 
HCMV, EBV, HSV-1, or VZV between the 
SAP and AAP by DNA and RNA analyses. 
(94) 
HCMV (92%), EBV 
(61%), HSV (0%). 
HCMV (7%), EBV (0%), 
HSV (0%) 
HCMV and EBV occurred at higher frequency 
in SAP showing radiographic bone 
destruction.  
(97) 
HCMV (53.6%), EBV 
(3.6%), coinfection 
HCMV/EBV (0%) 
HCMV (27.3%), EBV 
(4.5%), coinfection 
HCMV/EBV (4.5%) 
HCMV was most frequent in SAP. Significant 
differences were observed between SAP and 
AAP.   
(98) 
HCMV (62.5%), EBV 
43.7%), coinfection 
HCMV/EBV (25%) 
HCMV (41.7%), EBV 
(25%), coinfection 
HCMV/EBV (16.7%) 
The difference in occurrence of HCMV and 
EBV DNA between SAP and AAP was not 
statistically significant.  
(99) 
HCMV (100%), EBV 
(0%), coinfection 
HCMV/EBV (76%),  
HCMV (37%), EBV 
(25%), coinfection 
HCMV/EBV (26%), 
The difference in occurrence of HCMV and 
EBV between SAP and AAP was statistically 
significant. EBV may contribute to periapical 
pathogenesis in a subset of SAP.  
(100) 
HHV-6 (29%), EBV 
(53%), HCMV (0%), 
coinfection HHV6/ EBV 
(23%), coinfection 
HCMV/EBV (6%). 
HHV-6 (13%), EBV 
(47%), HCMV (4%), 
coinfection HHV6/ EBV 
(13%), coinfection 
HCMV/EBV (9%). 
HHV-6 was significantly higher in SAP 
samples than AAP samples (20% vs. 2.5%; P 
= .03). HHV-6-B was significantly associated 
with large-sized and symptomatic lesions. 
EBV and HHV-6B infections can be 
associated with SAP. 
(105, 
106) 
HCMV/EBV (69%), 
HCMV or EBV (30%), 
neither HCMV nor EBV 
(0%). 
HCMV/EBV (36%), 
HCMV or EBV (9%), 
neither HCMV nor EBV 
(54%). 
Higher occurrence of herpesvirus was detected 
in large versus small periapical lesions and in 
SAP. (95) 
HCMV (55%), EBV 
(88.9%), coinfection 
HCMV/EBV (44%),  
HCMV (0%), EBV (0%), 
coinfection HCMV/EBV 
(0%), 
The difference in occurrence of HCMV and 
EBV between SAP and AAP was statistically 
significant. No viruses were detected in the 
asymptomatic group. 
(101) 
HCMV (0%), EBV 
(72%) 
HCMV (0%), EBV (28%) Although there was an obvious association of 
the virus with SAP and AAP, it is unlikely 
that these viruses play a major role in the 
pathogenesis of AP. 
(108) 
HCMV (15%), EBV 
(70%), coinfection 
HCMV/EBV (15%) 
HCMV (0%), EBV (39%) Association between EBV, specific bacterial 
anaerobic infection, and SAP was found in 
peri-implants. 
(104) 
HCMV (58%), EBV 
(67%), coinfection 
HCMV/EBV (33%) 
 HCMV and EBV play a putative role in the 
pathogenesis of SAP in deciduous teeth. (102) 
HCMV (100%), EBV 
(100%), coinfection 
HCMV/EBV (100%), 
 HCMV and EBV participate in the 
pathogenesis of SAP. (103) 
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 HCMV (23%), EBV 
(31%), coinfection 
HCMV/EBV (14%), 
No significant difference was found when 
comparing the prevalence of these two viruses 
in AAP. HCMV was significantly more 
frequent in AAP cases from HIV-positive 
patients (67%) than in lesions from HIV-
negative patients (8%).  
(109) 
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Pain and inflammation 
Expression of cytokines 
 
Cytokines are proteins secreted by cells that mediate multiple immunologic, non-
immunologic biological function and have a specific effect on the interactions and 
communications between cells (110, 111). Inflammatory cells such as, neutrophils, macrophages, 
T lymphocytes, B lymphocytes, plasma cells, and dendritic cells are activated by the presence of 
cytokines produced by surrounded cells (i.e. dental and bone cells and nerves) due to bacteria 
endotoxin that reaches the apical region (112-120). T helper (Th) cells play an important role 
producing cytokines exerting different functions. Th1 cells are characterized by production of 
interferon-γ (IFN-γ), interleukins (IL-2, IL-11, IL-12) and TNF-α and are involved in the 
progression of periapical lesions and bone destruction (121). Th2 cells secrete interleukins (IL-4, 
IL-5, IL-6, IL-10, and IL-13) and together with transforming growth factor (TGF-β)  mediate the 
healing processes occurring in the late stage of AP development and down-regulation of the 
inflammatory reaction (121). Table 3 shows studies of cytokines expression in AP and summaries 
of the results.  
Indeed, the synergistic interaction between cytokines, specifically IL-1, IL-6, TNF-α, IL-8 
and IL-17, regulates the pathogenesis of AP in human (110, 122-124). Majority of the studies 
reported higher level of cytokines in periapical lesions and significant differences were observed 
between SAP and AAP (101, 110, 122-130). Gazivoda et al. studied the correlation between 
proinflammatory and immunoregulatory cytokines in periapical lesions and their relationship with 
cellular composition and clinical presentation (126). Large-size lesions showed lower percentages 
of mononuclear phagocytes and produced higher levels of TNF-α, IL-6 and IL-10 compared with 
small-size lesions (126). Martinho et al. reported that IL-6 and PGE2 were correlated with pain 
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but not with size of the radiographic lesion, whereas IL-6 and TNF-α were positively correlated 
with size of the radiographic lesion and exudate (131). Chronic AP may involve specific T- and 
B-cell-mediated anti-bacterial responses and activate a network of regulatory cytokines which are 
produced by Th1- and Th2-type T-lymphocytes (96, 121).  
The mechanism of pain may be associated with the release of cytokines which induce the 
trigeminal afferent neurons to express receptors, such as TLR4 and CD14 receptor complex, that 
may trigger intracellular signaling cascades, leading to the peripheral release of neuropeptides and 
central nociceptive neurotransmission (127). Other substance such as matrix metalloproteinases 
(MMP-9) and monocyte chemotactic proteins (MCP) may be related to inflammation and 
mechanisms of pain (127, 132). MMP-9 is essential for initiating the osteoclastic resorption and it 
regulates neuropathic pain after peripheral nerve injury through degenerative and proinflammatory 
mechanisms (127). MCP-3 is a chemokine that acts predominantly on macrophages, highly 
expressed in chronic inflammatory disorders and bone resorption (132). Both MMP-9 and MCP-
3 were significantly expressed in SAP cases than AAP cases (127, 132). The presence of viruses 
also correlates with the expression of cytokines in symptomatic periapical lesions  (101, 102).  It 
has been suggested that HCMV and EBV infections in periapical lesions may explain various 
pathological features of the inflammatory process (103). They may trigger the release of cytokines 
from inflammatory cells, but the cause for differing periapical levels of these proinflammatory 
mediators and bone resorption-stimulating molecules has not been established (103). 
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Table 3 – Expression of cytokines in SAP and AAP. IL-interleukin; GM-CSF-granulocyte-macrophage colony-stimulating factor; 
TNF-α -  tumor necrosis factor-α; LTB4 – leukotriene B4; MMP - matrix metalloproteinase; Th - T helper; MCP-3 - monocyte 
chemotactic protein-3; PGE2 - Prostaglandin E2; γIFN - Interferon gamma. 
 
 
 
 
Expression of 
cytokines 
Results          Ref 
IL-6, GM-CSF Higher levels of IL-6 and GM-CSF was found in symptomatic than in 
asymptomatic lesions, but the difference was not significant. 
(133) 
IL-8 Significantly higher IL-8 levels were found in SAP. (122) 
IL-1β Higher level of IL-1β was found in SAP compared with AAP lesions, 
but the difference was not significant. 
(116) 
LTB4 Higher concentrations of LTB4 were found in SAP compared with 
AAP. 
(125) 
TNF-α, IL-6 There were no significant differences in TNF- α levels between SAP 
and AAP. IL-6 levels were significantly higher in SAP than AAP. 
(123) 
IL-1, IL-6, IL-8, 
IL-10 
Inflammatory cells from SAP secreted higher levels of IL-1, IL-6 and 
IL-8 compared with asymptomatic lesions. 
(126) 
MMP-9 SAP showed statistically significant increased numbers of gram-
negative bacteria and higher MMP-9 expression than the AAP.  
(127) 
Neutrophil 
elastase 
SAP cases showed higher neutrophil elastase levels than AAP cases. (134) 
IL-17 SAP cases showed high production of IL-17 than AAP cases. (128) 
Th1, Th2 No correlation was found between the levels of Th1 and Th2 cytokines 
and symptoms. 
(121) 
MCP-3 MCP-3 levels were significantly higher in SAP than in AAP. (132) 
TNF-α, IL-1β Higher levels of IL-1β in groups with clinical signs, but the differences 
were not significant.  
(135) 
CD14, TNF-α, 
IL1β, IL6, IL10 
Predominance in symptomatic cases: high IL-6; intermediate to high 
IL1B and low TNF-α. 
(129) 
Il-17, IL-8 There was a positive correlation between the levels of IL-17 and IL-8 
in the group of symptomatic lesions. 
(130) 
TNF-α, IL1β, IL6, 
IL10, PGE2  
IL-6 and PGE2 were correlated with pain but not with size of the 
radiographic lesion.  
(124) 
RANK RANKL expression showed significantly higher occurrence in 
periapical pathosis than in healthy pulpal tissue. No relationship was 
found between RANK and SAP and AAP. 
(102) 
TNF-α, γ-IFN, IL-
1, and IL-12 
There was a significant correlation between TNF, γ-IFN, IL-1, IL-12 
and EBV, HCMV in SAP cases. 
(101) 
TNF-α Highest concentrations of TNF-α were found in SAP and slightly less 
in AAP. 
(110) 
Endotoxin A positive association was found between endotoxin and symptomatic 
cases (e.g. spontaneous pain, tenderness to percussion, pain on 
palpation, swelling and purulent exudates) 
(136, 
137) 
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Bone resorption in periapical lesions  
 
Bone resorption in the periapical region is one of the clinical hallmarks of periapical 
pathosis. It is controlled by inflammatory and anti-inflammatory cytokines which influence the 
differentiation of mononuclear cells into osteoclasts, or other cell lineages such as dendritic cells 
and macrophages. Figure 4 shows the mechanisms of bone resorption by osteoclasts in AP (138, 
139). Osteoclast activation by cytokines (TNF-α, IL-1 and IL-17) is mediated by the formation of 
cyclooxygenase pathway products such as prostaglandins (138, 139). Nuclear factor kappa B (NF-
kB)–ligand (RANKL) induces bone resorption, whereas osteoprotegerin (OPG) acts to neutralize 
these effects. RANKL messenger RNA expression is significantly higher in periapical lesions 
(140-142).   
 
 
Figure 4. Bone resorption by osteoclasts in AP. DC, Dendritic cell; HSC, 
hematopoietic stem cell; Mφ, macrophage; MSC, mesenchymal stromal cell; Nφ, 
neutrophil; OB, osteoblast; OC, osteoclast; OCP, osteoclast precursor; OPG, 
osteoprotegerin; RANK, receptor activator of nuclear factor κB; RANKL, 
receptor activator of nuclear factor κB ligand. (21) 
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Animal models of AP 
Studying AP in humans has some significant limitations such as their cross-sectional 
nature, restricted ethical reasons, and only association with symptoms instead of a cause-and-effect 
relationship can be inferred. The development of AP has been elucidated using animal models by 
dental pulp exposure. The animal is anesthetized, and the pulp is exposed for several days to the 
oral environment or inoculated with bacterial species associated with human endodontic infections 
(143). The progression of the disease is confirmed radiographically by the presence of periapical 
radiolucency. The use of advanced analysis techniques and genetically engineered animals such 
as mice and rats have been useful to clarify the etiopathology of this condition, improve diagnosis, 
and search for new therapeutic options. 
Expression of cytokines in animal models  
 
AP has been studied in different animal models (Table 4). In mice and rats, cytokines were 
expressed after 2 days pulp exposure and periapical lesion were observed between induction on 
day 0 and day 15 ("active phase"), increasing the lesion at a slower rate at days 20 and 30 ("chronic 
phase") (139, 143, 144).   IL-1α and TNF-α were highly expressed at day 7 and increased at day 
28, while IL-6 increased at day 14 and then declined (145). Th1-type cytokines (IL-2, IL-12, and 
IFNγ) showed an increase expression in periapical lesions, while the expression of Th2-type 
cytokines (IL-4, IL-6, IL-10, IL-13) was similarly increased, but they declined at the latest at day 
28, suggesting possible inhibition by Th1-type mediators. This evidence indicates that a cytokine 
network is activated in response to bacterial infection, and that Th1-modulated pro-inflammatory 
pathways may predominate during periapical bone destruction (145). Similar results were reported 
in a rat model of AP, where bone resorption stimulated by bacterial infection was primarily 
mediated by IL-1α (139). In another study, AP in mice progressively increased the number of 
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osteoclasts and cementoclast, and the mRNA levels of RANK, RANKL, and Cathepsin K (CatK) 
after 7, 21, and 42 days pulp exposure. The endotoxin from bacteria bind to their specific receptors 
in immune cells (monocytes, macrophages and neutrophils) and activates intracellular pathways 
(i.e. transcriptional factor NF-κβ) which upregulates pro-inflammatory cytokines promoting bone 
resorption (146-148). It was reported that cytolytic E. faecalis strain induced local IL-1β and 
MMP-8 expression causing severe local inflammation and tissue destruction in persistent AP in 
rats (149). Indeed, MMPs (MMP-2 and MMP-9) play a critical role in the development of 
inflammatory AP by degrading the extracellular matrix  (149, 150). 
AP elevated the levels of C-reactive protein, IL-2, and IL-6 in rat blood serum, causing 
reversible changes in the aortic arch, myocardium, spleen and in the liver (151). Therefore, AP 
contributes to the systemic immune response, which is not confined to the localized lesion, and 
can potentially trigger an increase in systemic inflammation impairing remote organs and affecting 
the general health of patients (147, 151). In another study, pregnant rats with AP had a significantly 
longer pregnancy and delivered pups with a significantly higher birthweight. They had 
significantly higher concentrations of IL-6, VEGF, IL-1β, and IL-10 within the uterine horn and 
IL-6, CRP and TNF-α within the liver (152). Furthermore, this study suggests that animals with 
induced AP developed insulin resistance, which significantly affected their pregnancy outcomes. 
Some diseases, such as diabetes, can enhance the development of AP (153, 154). 
Animals models of AP have also been used to elucidate the mechanisms of inflammatory 
pain. The dental pulp and periradicular tissues are innervated by nociceptive neurons which release 
neuropeptides such as calcitonin gene-related peptide (CGRP)  (155). Rat capsaicin-treated with 
induced AP showed a significant depletion of susceptible neurons and CGRP in the dental pulp, 
reveling a protective effect of the neurons in the initial phase of AP (155). Tarsa et al. demonstrated 
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that brain-derived neurotrophic factor (BDNF) is significantly upregulated in transient receptor 
potential vanilloid type 1 (TRPV1) immunoreactive (IR) neurons in both rats and mice, and CGRP-
IR neurons in mice, but not rats. The inflammation-induced upregulation of BDNF is stronger in 
mice compared to rats (156). 
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Table 4 – Animal models to study the development of AP. CGRP- Calcitonin gene-related peptide; CRP- C-reactive protein; 
RANK - receptor activator of nuclear factor kappa-B; RANKL - receptor activator of the nuclear factor kappa-B ligand; OPG – 
osteoprotegerin; 5-LO - 5-lipoxigenase; MIF - migration inhibitory factor; VEGFs - Vascular endothelial growth factors; 
VEGFRs - Vascular endothelial growth factors receptors; CIITA - class II transactivator, SAA - serum amyloid A; BDNF - brain-
derived neurotrophic factor; Cyr61 - Cysteine Rich Angiogenic Inducer 61; MMP - matrix metalloproteinase. 
Animal 
model 
Effect Results Ref. 
Cat 
Feline 
immunodeficiency 
virus (FIV) 
IL-1β production decreased in the FIV group. In the non-FIV group, IL-1β 
decreases at the chronic stage of the AP compared with the acute stage. (157) 
Dog Open versus sealed canals 
Induced AP inflammatory lesions by oral exposure, followed by tooth 
sealing, produced root canal microbiota similar to that found in humans. 
(158) 
Dog SAA, CRP Canine model provides a useful means for studying the systemic effects of AP, and it is not associated with elevated CRP or SAA. 
(159) 
Dog Pulp exposure and coronal sealing 
There was no histopathological difference among induced AP in the teeth 
with coronal sealing. 
(160) 
Ferrets Periapical lesion 
AP was visible in all teeth within 4 weeks. The induced lesions consisted 
principally of a mononuclear inflammatory infiltrate, dominated by 
macrophages but with numerous lymphocytes. 
(148) 
Mice 
RANK, RANKL, 
OPG, and 
cathepsin K 
Cementocytes express RANKL in response to endodontic infection in AP. (161) 
Mice 
IL-1α, TNF-α, IL-
6, IL-11], IL-2, IL-
12, IFNγ, IL-4, IL-
6, IL-10, IL-13 
A cytokine network is activated in the periapex in response to bacterial 
infection, and that Th1-modulated pro-inflammatory pathways may 
predominate during periapical bone destruction.  
(145) 
Mice IL-9 and IL-22 
Increasing levels of IL-9 and IL-22 mRNA were detected in AP, and 
inverse correlations were found between IL-9 and IL-22 and the increase 
of lesion area in the different time point intervals. 
(162) 
Mice 
IL-1β, TNF-α, 
RANK, MCP-1 
RANKL, 
Nitric oxide, but not reactive oxygen species, controls expression of 
cytokines and progression of bone resorption in AP. (163) 
Mice IL-6 IL-6
-/- mice developed AP more rapidly than IL-6+/+ mice. (164) 
Mice IL-10, IL-4 
IL-10, but not IL-4, is an important endogenous suppressor of infection-
stimulated bone resorption in vivo, likely acting via inhibition of IL-1α 
expression. 
(165) 
Mice/ 
Rat BDNF 
Mouse TG provides a suitable model to study molecular mechanisms of 
inflammation-dependent regulation of BDNF expression in vivo. 
(156) 
Rat Bone resorbing Bone-resorbing activity is temporarily related to periapical bone destruction in AP rat model. 
(144) 
Rat IL-1α, TNF-α IL-1α plays a key role in the pathogenesis of AP in the rat mode. (143) 
Rat IL-1α, TNF-α Bone resorption stimulated by bacterial infection is primarily mediated by IL-1α in AP rat model. 
(139) 
Rat Odontogenic cysts Inflammatory stimulation from the apices can cause cystic changes in the enamel epithelium of underlying teeth. 
(166) 
Rat Root canal treatment 
AP model using rats can be used in developmental research for novel 
methods of root canal treatment. 
(167) 
Rat Lipopolysaccharide (LPS) 
Induced AP in animal model by exposing pulps and placing LPS, and 
exposing to the oral environment is similar to human natural progress of 
the same disease and has a shorter time duration.  
(168) 
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Rat CGRP Capsaicin-sensitive neurons has a protective effect in the initial phase of AP.  
(155) 
Rat CRP, IL-2, and IL-6 
AP elevated the levels of CRP, IL-2, and IL-6 in rat blood serum, causing 
reversible changes in the aortic arch, myocardium, and spleen as well as 
irreversible changes in the liver.  
(151) 
Rat IL-1β. IL-1α 
203 genes were up-regulated to more than 5-fold (IL-1β. IL-1α), and 864 
genes were down-regulated to less than 20% of baseline level (e.g., 
caspase 8) in inflammation phase of AP. 
(169) 
Rat Sirtuin 6 Development of AP in rats was associated with decreased expression of SIRT6 and increased glycolysis and apoptosis in osteoblasts. 
(170) 
Rat IL-1β and MMP-8 
IL-1β expression enhancement occurred during the early phase of 
infection, whereas increased MMP-8 expression lasted for a prolonged 
period. 
(149) 
Rat 
Sympathetic 
nerves, IL-1α, 
TNF-α 
Sympathetic nerves have an inhibitory effect on IL-1 α in AP and a 
stimulatory effect on TNF- α in the intact rat pulp. (171) 
Rat IL-17 
The combination of AP and periodontal disease increased the serum IL-17 
levels in diabetes and normoglycemic rats and increased the neutrophil 
levels in diabetes rats. Diabetes increased the neutrophil levels and bone 
resorption in rats. 
(7) 
Rat MIF, RANK, RANKL 
These findings showed that MIF might be associated with the 
differentiation of osteoclasts in AP. MIF contributes to the pathogenesis of 
the AP through the induction of RANKL protein. 
(172) 
Rat VEGFs, VEGFRs VEGF family and receptors are involved in vascular remodeling and immune functions during AP development. 
(173) 
Rat CIITA, TNF-α, Cyr61 
CIITA might play a protective role in the pathogenesis of bone resorption 
in AP, possibly through down-regulating the expression of Cyr61 in 
osteoblasts. 
(174) 
Rat Pregnancy Blood glucose and serum TNF-α, IL-6, endothelin-1, IL-10, and insulin concentrations were significantly higher in the pregnant animals with AP. 
(152) 
Rat CD14, TLR4 
CD14 and TLR4 may play important roles in the pathogenesis of AP, 
probably via immune cells such as monocytes/macrophages and 
neutrophils. 
(146) 
Rat MMP-2, MMP-9 
MMP-2 and MMP-9 play critical roles in the development of inflammatory 
AP, probably involved in the extracellular matrix (ECM) degradation 
during the initial phase of the lesion development. 
(150) 
Rat Diabetes The metabolic conditions produced by type 2 diabetes enhance the development of AP in rats. 
(153) 
Rat Streptozotocin-induce diabetic 
Inflammation and root resorption and alveolar bone resorption were more 
severe in streptozotocin-induced diabetic rats than that in control rats. 
(154) 
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Treatment of AP in animal models  
 
Although the success rate of endodontic treatment for AP is approximately 80%, there is 
still an urgent need for increased efficacy of treatment (175). Table 5 shows a list of possible 
molecules for the treatment of AP. For instance, odanacatib, dexamethasone, simvastatin, tempol, 
tactivin, polymyxin B, osteopontin, epigallocatechin-3-gallate and bisphosphonates prevented the 
AP development in mice and rat models (7, 176-184). In the case of simvastatin molecule, it 
attenuated bone resorption, reduced osteoblastic expressions of cysteine rich angiogenic inducer 
61 (Cyr61), transcription factor p-FoxO3a, and chemokine CCL2, and suppressed macrophage 
recruitment (177, 180). Atp6i RNAi can ameliorate the development of endodontic disease by 
reducing bone resorption and inflammation (175). 
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Table 5. Animal models to study the treatment of AP 
Animal 
model 
Effect Results Ref. 
Cat 
Feline 
immunodeficiency 
virus (FIV) 
IL-1β production decreased in the FIV group. In the non-FIV group, IL-1β 
decreases at the chronic stage of the AP compared with the acute stage. (157) 
Dog Open versus sealed canals 
Induced AP inflammatory lesions by oral exposure, followed by tooth 
sealing, produced root canal microbiota similar to that found in humans. 
(158) 
Dog SAA, CRP Canine model provides a useful means for studying the systemic effects of AP, and it is not associated with elevated CRP or SAA. 
(159) 
Dog Pulp exposure and coronal sealing 
There was no histopathological difference among induced AP in the teeth 
with coronal sealing. 
(160) 
Ferrets Periapical lesion 
AP was visible in all teeth within 4 weeks. The induced lesions consisted 
principally of a mononuclear inflammatory infiltrate, dominated by 
macrophages but with numerous lymphocytes. 
(148) 
Mice 
RANK, RANKL, 
OPG, and 
cathepsin K 
Cementocytes express RANKL in response to endodontic infection in AP. (161) 
Mice 
IL-1α, TNF-α, IL-
6, IL-11], IL-2, IL-
12, IFNγ, IL-4, IL-
6, IL-10, IL-13 
A cytokine network is activated in the periapex in response to bacterial 
infection, and that Th1-modulated pro-inflammatory pathways may 
predominate during periapical bone destruction.  
(145) 
Mice IL-9 and IL-22 
Increasing levels of IL-9 and IL-22 mRNA were detected in AP, and 
inverse correlations were found between IL-9 and IL-22 and the increase 
of lesion area in the different time point intervals. 
(162) 
Mice 
IL-1β, TNF-α, 
RANK, MCP-1 
RANKL, 
Nitric oxide, but not reactive oxygen species, controls expression of 
cytokines and progression of bone resorption in AP. (163) 
Mice IL-6 IL-6
-/- mice developed AP more rapidly than IL-6+/+ mice. (164) 
Mice IL-10, IL-4 
IL-10, but not IL-4, is an important endogenous suppressor of infection-
stimulated bone resorption in vivo, likely acting via inhibition of IL-1α 
expression. 
(165) 
Mice/ 
Rat BDNF 
Mouse TG provides a suitable model to study molecular mechanisms of 
inflammation-dependent regulation of BDNF expression in vivo. 
(156) 
Rat Bone resorbing Bone-resorbing activity is temporarily related to periapical bone destruction in AP rat model. 
(144) 
Rat IL-1α, TNF-α IL-1α plays a key role in the pathogenesis of AP in the rat mode. (143) 
Rat IL-1α, TNF-α Bone resorption stimulated by bacterial infection is primarily mediated by IL-1α in AP rat model. 
(139) 
Rat Odontogenic cysts Inflammatory stimulation from the apices can cause cystic changes in the enamel epithelium of underlying teeth. 
(166) 
Rat Root canal treatment 
AP model using rats can be used in developmental research for novel 
methods of root canal treatment. 
(167) 
Rat Lipopolysaccharide (LPS) 
Induced AP in animal model by exposing pulps and placing LPS, and 
exposing to the oral environment is similar to human natural progress of 
the same disease and has a shorter time duration.  
(168) 
Rat CGRP Capsaicin-sensitive neurons has a protective effect in the initial phase of AP.  
(155) 
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Rat CRP, IL-2, and IL-6 
AP elevated the levels of CRP, IL-2, and IL-6 in rat blood serum, causing 
reversible changes in the aortic arch, myocardium, and spleen as well as 
irreversible changes in the liver.  
(151) 
Rat IL-1β. IL-1α 
203 genes were up-regulated to more than 5-fold (IL-1β. IL-1α), and 864 
genes were down-regulated to less than 20% of baseline level (e.g., 
caspase 8) in inflammation phase of AP. 
(169) 
Rat Sirtuin 6 Development of AP in rats was associated with decreased expression of SIRT6 and increased glycolysis and apoptosis in osteoblasts. 
(170) 
Rat IL-1β and MMP-8 
IL-1β expression enhancement occurred during the early phase of 
infection, whereas increased MMP-8 expression lasted for a prolonged 
period. 
(149) 
Rat 
Sympathetic 
nerves, IL-1α, 
TNF-α 
Sympathetic nerves have an inhibitory effect on IL-1 α in AP and a 
stimulatory effect on TNF- α in the intact rat pulp. (171) 
Rat IL-17 
The combination of AP and periodontal disease increased the serum IL-17 
levels in diabetes and normoglycemic rats and increased the neutrophil 
levels in diabetes rats. Diabetes increased the neutrophil levels and bone 
resorption in rats. 
(7) 
Rat MIF, RANK, RANKL 
These findings showed that MIF might be associated with the 
differentiation of osteoclasts in AP. MIF contributes to the pathogenesis of 
the AP through the induction of RANKL protein. 
(172) 
Rat VEGFs, VEGFRs VEGF family and receptors are involved in vascular remodeling and immune functions during AP development. 
(173) 
Rat CIITA, TNF-α, Cyr61 
CIITA might play a protective role in the pathogenesis of bone resorption 
in AP, possibly through down-regulating the expression of Cyr61 in 
osteoblasts. 
(174) 
Rat Pregnancy Blood glucose and serum TNF-α, IL-6, endothelin-1, IL-10, and insulin concentrations were significantly higher in the pregnant animals with AP. 
(152) 
Rat CD14, TLR4 
CD14 and TLR4 may play important roles in the pathogenesis of AP, 
probably via immune cells such as monocytes/macrophages and 
neutrophils. 
(146) 
Rat MMP-2, MMP-9 
MMP-2 and MMP-9 play critical roles in the development of inflammatory 
AP, probably involved in the extracellular matrix (ECM) degradation 
during the initial phase of the lesion development. 
(150) 
Rat Diabetes The metabolic conditions produced by type 2 diabetes enhance the development of AP in rats. 
(153) 
Rat Streptozotocin-induce diabetic 
Inflammation and root resorption and alveolar bone resorption were more 
severe in streptozotocin-induced diabetic rats than that in control rats. 
(154) 
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In this study, we aim to examine the development of AP in CBM mice. This study is 
significant in the following aspects: 
1. Examine periapical bone loss and inflammation levels in CBM mice after pulp 
exposure. 
2. Investigate if increased host inflammatory response in CBM mice exacerbates AP. 
So far, there is no study on how AP develops in CBM. Since CBM mice and patients have 
increased inflammatory response, we ask whether AP develops differently compared to healthy 
subjects.  
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Chapter II: Research aims and hypothesis 
 
Research aim 
Development and characterization of AP in CBM mice 
Hypothesis 
AP may be exacerbated by the increased host inflammatory response in CBM mice. 
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Chapter III: Materials and Methods 
 
Mice 
CBM mouse model was generated as described on the previous study (4). Briefly, proline-
to-arginine (P416R) missense mutation in exon 9 of murine SH3BP2 was induced using a targeting 
construct containing a 20 kb gene fragment, a Neo-cassette flanked by loxP sites inserted between 
exons 8 and 9, a mutated exon 9, and a thymidine kinase cassette at the 3’ end. Mice were crossed 
with a cre-deleter strain to remove the Neo cassette in the SH3BP2 gene. Then, mice carrying 
SH3BP2 knock-in (KI) alleles were backcrossed to C57BL6/J mice. All animals were housed in 
specific pathogen free facilities and monitored carefully, following strict guidelines for humane 
care and treatment of animals. For this study, the experiments were carried out on 8-wk-old 
sh3bp2+/+, sh3bp2+/KI and sh3bp2KI/KI male and female mice. Mice were housed in small unisex 
groups in a temperature-controlled room (22–24 °C) on a 12 h light/dark cycle, with access to food 
and water ad libitum. The animal protocol (101297-0119) was approved by the Center of 
Comparative Medicine at the University of Connecticut Health. 
For genotyping of wild-type and mutant animals, PCR with primers (P1 and P2) from 
within intron 8 of the SH3BP2 gene was used. The sequences of these primers are: P1 (sense): 5’ 
CCACTATATGACAATACCTG 3’; P2 (antisense): 5’ CATAGTCTTCATCTGAGTCC 3’. For 
sequencing the SH3BP2 gene in wild-type, heterozygous and homozygous mutants, DNA was 
isolated from mouse tail. The genotyping was performed before mouse weaning and after each 
time point. 
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Periapical lesion induction   
Induction of periapical lesions was performed as described previously (185). Briefly, the 
mice were anesthetized by an intraperitoneal injection of ketamine/xylazine (ketamine 100-120 
mg/kg, xylazine 5-10 mg/kg). Mice were then mounted on a jaw retraction board. Access to the 
pulp chamber of the mandibular right first molars was gained with stainless-steel #1/4 round burs 
(Brasseler USA, Savannah, GA) in a low-speed handpiece under the microscope and fiber light 
(Fiber-Lite® Mi-LED, Dolan-Jenner, MA, USA). Canals were localized and explored with a 23/6 
explorer (Hu-Friedy USA, Chicago, IL) and left exposed to the oral cavity for lesion induction. 
Left side mandibles were used as control. Mice with or without pulp exposure were subjected to 
weight measurement after 1, 3, 6, 9, 13, 17 and 21 days. They were sacrificed after each time point 
in a CO2 chamber as demonstrated in the Figure 5. Percentage of weight change normalized to day 
Figure 5. Schematic view of Materials and Methods 
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0 over 21 days was determined. Here we only included date from male mice. The following group 
of mice were used: at day 3 (sh3bp2+/+ n= 6, sh3bp2+/KI n=5, sh3bp2KI/KI n =5), 7 (sh3bp2+/+ n =6, 
sh3bp2+/KI n =3, sh3bp2KI/KI n =4), 14 (sh3bp2+/+n=3, sh3bp2+/KI n=3, sh3bp2KI/KI n=3) and 21 
(sh3bp2+/+ n=5, sh3bp2+/KI n=3, sh3bp2KI/KI n=4). 
 
 
Faxitron x-ray and micro-CT analysis 
Both left and right mandibles were dissected and attached muscle was grossly removed. 
Mandibles were fixed in 4% paraformaldehyde (PFA) (EMS, Hatfield, PA, USA) for 48 hours. 
Samples were radiographically imaged using a Faxitron™ (Faxitron Bioptics, Tucson, AZ, USA) 
with the exposure time of 3 seconds and voltage of 26 kV at days 3, 7, 14 and 21. High resolution 
micro–computed tomography (micro-CT) scans (Scanco µCT 40, Scanco Medical, AG, 
Bassersdorf, Switzerland) were obtained on right and left mandibles of sh3bp2+/+, sh3bp2+/KI and 
sh3bp2KI/KI male mice (n=3 for each group) 21 days after pulp exposure. Serial images were 
acquired transverse to the longitudinal axis of the hemimandible at 55 kVp (145 µA), employing 
1000 cone-beam projections per revolution at an integration time of 300 ms within a 12.3 mm field 
of view.  Three-dimensional image arrays were reconstructed using standard convolution back-
projection algorithms with Shepp and Logan filtering, and rendered at an isometric spatial 
resolution of 12 µm voxels. 
 
Hematoxylin staining and immunohistochemical analysis 
For hematoxylin staining and immunohistochemical (IHC) analysis, mandibles were fixed 
and demineralized in 14% ethylenediaminetetraacetic acid (EDTA) which was changed every 3 
days for 20 days at 4°C. Once decalcified, the dissected mandibles were processed according to 
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the Table 6. Then, they were embedded in paraffin (15×15×5 mold blocks) and serial sections of 
6µm were prepared from the blocks using Leica RM2125 RT (Leica Biosystems Inc. IL, USA). 
Sections were deparaffinized in xylene (2×5 min) and then hydrated serial ethanol dilution 
(100, 95, 75 and 50%) for 2 min each. After rinsing in distilled water, sections were treated with 
citrate buffer pH 6.0 at 60°C water bath overnight for a heat mediated antigen retrieval. Samples 
were washed in PBS-1% Tween 20 three times wash, 5 minutes each time, and then, they were 
incubated with 2.5% normal goat serum for 30 min at RT. Samples were incubated with primary 
antibody anti-mouse CatK (SC-48353, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at the 
dilution of 1:50 (1% BSA-PBS) for 2 hours at room temperature for osteoclast staining. After 
rinsing three times wash, 5 minutes each time, with PBS, peroxidase activity was blocked with 3% 
H2O2 for 10 minutes at room temperature followed by three times wash, 5 minutes each time, with 
PBS. Next, they were incubated with secondary antibody goat anti-mouse IgG-HRP (Pierce 32230, 
Thermo Fisher Scientific, Waltham, MA, USA) for 1 hour at room temperature followed by three 
times wash, 5 minutes each time, with PBS. Color was developed using chromogen/substrate in 
DAB (5ml distilled water, 2 drops/84µl buffer, 4 drops/100µl DAB, 2 drops/80µl HPS) for 3 
minutes. After washing with PBS twice, samples were counterstained with haematoxylin for 10 
seconds before dehydration (95% ethanol for 2 min, 100% ethanol for 2×3 min), clearing (xylene 
for 2×5 min) and mounting with SP15-100 Permount™ Mounting Medium (Fisher Scientific, 
Hampton, NH, USA). The sections were scanned under the Axio Imager.Z1 microscope (Carl 
Zeiss MicroImaging GmbH, Göttingen, Germany) coupled to an AxioCam MRm camera (Carl 
Zeiss MicroImaging GmbH). 
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Table 6 Paraffin embedding protocol 
 
 
Station Hours:Min. Reagent 
1 1:00 PBS 
2 1:00 PBS 
3 1:00 PBS 
4 0:15 NaCl 
5 0:15 NaCl/50% Ethanol 
6 0:01 50% Ethanol 
7 0:20 50% Ethanol 
8 0:20 50% Ethanol 
9 0:20 50% Ethanol 
10 0:20 70% Ethanol 
11 0:20 70% Ethanol 
12 0:20 70% Ethanol 
13 0:20 95% Ethanol 
14 0:20 95% Ethanol 
15 0:20 95% Ethanol 
16 0:20 100% Ethanol 
17 0:20 100% Ethanol 
18 0:20 100% Ethanol 
19 0:10 Ethanol:Xylene 1:1 
20 0:10 Xylene 
21 0:10 Xylene 
22 0:10 Xylene 
23 overnight 1:1 Xylene/Paraffin 
24 1:00 Paraffin 
25 1:00 Paraffin 
26 1:00 Paraffin 
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Quantitative analysis of osteoclast numbers 
The analysis was performed in the same stained sections using the microscope at ×10 
magnification operating in the bright field mode. After capturing the area, CatK(+) osteoclasts 
area, numbers and the bone perimeter around the periapical of mandibular first molar were 
measured as described (186, 187) using Digimizer Image Analysis software (MedCalc Software 
bvba, Ostend, Belgium) as shown in Figure 6. 
 
Statistical analysis 
The results for weight change, CatK(+) cell numbers and the ratio of the CatK(+) area to 
the periapical bone perimeter were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc., 
Figure 6. The ratio of Cat-K+ area to the bone perimeters (A) and number of CatK(+) cells (B) around the periapex of first 
molar were measured by Digimizer software. 
A B
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La Jolla, CA, USA). Comparisons among multiple experimental groups over time were performed 
by two-way ANOVA.  
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Chapter IV: Results 
 
Effect of AP on weight loss  
In this study, dental pulp exposure method was used to induce AP in CBM mouse model. 
Experimental sh3bp2KI/KI mice showed significant body weight loss on days 6, 13, 17 and 21 
compared to that of sh3bp2+/+ and sh3bp2+/KI (P value < 0.05). Sh3bp2+/+ and sh3bp2+/KI mice 
recovered their weight after 7 days. However, sh3bp2KI/KI mice continued to lose weight until 21 
days after pulp exposure, suggesting pulp exposure leads to initial weight loss (Figure 7A). In 
control mice without infection, sh3bp2+/+ and sh3bp2+/KI mice gained weight for 21 days, whereas, 
sh3bp2KI/KI mice started losing weight at day 9 however the amount of weight loss was 
significantly more in sh3bp2KI/KI mice receiving dental procedures (Figure 7B).  
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Figure 7. Percentage (%) of body weight normalized to day 0 over 21 days in experimental (A) and control (B) groups. 
sh3bp2KI/KI mice lost body weight until 21 days after pulp exposure. 
B 
* 
* 
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A 
* 
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* 
* 
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Radiographs of periapical lesions 
The successful pulp exposure of each molar was validated by Faxitron radiography. 
Periapical radiolucency is the radiographic sign of inflammatory bone lesions in the apical of the 
tooth. We determined the prevalence of periapical radiolucency in CBM mice over time. 
Radiographs of mandibles showed noticeable periapical radiolucency in the sh3bp2+/KI and 
sh3bp2KI/KI mice after 3 days of pulp exposure (Figure 8). Whereas, sh3bp2+/+ showed no evident 
radiolucency at day 3. Sh3bp2+/KI mice showed a consistent intermediate phenotype through all 
assays and all time points. Left 1st molars without pulp exposure from the same mice showed no 
periapical radiolucency. 
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Figure 9 shows the progression of periapical bone destruction from day 7 to day 21. In 
sh3bp2+/+ and sh3bp2+/KI mice, periapical radiolucency developed over time. sh3bp2KI/KI mice 
showed periapical lesions in all time points and lesions were most severe at day 14. No periapical 
lesions were observed in the controls. 
Figure 8. Representative radiographs of mandibles after 3 days of pulp exposure showing noticeable periapical 
radiolucency in the sh3bp2+/KI and sh3bp2KI/KI mice as indicated by arrows. Left side mandibles were used as control.   
Sh3bp2+/+
Sh3bp2+/KI
Sh3bp2KI/KI
Control (Left) Infection (Right)
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Micro-CT images of periapical bone loss  
Micro-CT, a high-resolution imaging modality, was used to analyze the bone resorption 
progression after pulp exposure in CBM mice.  Figure 10 shows the micro-CT images of mandibles 
after 21 days pulp exposure. The results showed that significantly more bone destructions in 
periapical areas of sh3bp2+/KI and sh3bp2KI/KI mice compared to the sh3bp2+/+ littermates, which 
was more confined and limited to the periapex. No bone loss in the periapical area was observed 
in control molars.  
Figure 9. Representative radiographs showing the progression of periapical bone destruction from day 7 to day 21. 
Sh3bp2+/+
Sh3bp2+/KI
Sh3bp2KI/KI
Day 14Day 7 Day 21
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Histologic sections of periapical inflammation 
Representative paraffin-embedded sections were stained with CatK immunohistochemistry 
followed by hematoxylin for a descriptive analysis of the pulp tissue and apical and periapical 
regions under light microscopy and for the determination of the periapical lesion size. Figure 11A 
shows CatK IHC staining in control molar sections. Before pulp exposure, molars have vital pulp 
tissues with no obvious inflammation in all three groups. Three days after pulp exposure, the 
inflammation was obvious in root canals and part of periapical area of sh3bp2KI/KI mice. Sh3bp2+/KI 
Figure 10. Representative micro-CT images from controls and experimental groups after 21 days of pulp exposure. 
Control M Control D Infected M Infected D
Sh3bp2+/+
Sh3bp2+/KI
Sh3bp2KI/KI
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mice showed intermediate phenotype. Pulp necrosis progressed more rapidly in sh3bp2KI/KI mice 
compared to sh3bp2+/+ and sh3bp2+/KI mice (Figure 11B).  
 
 
 
Figure 11.(A): Representative IHC/H CatK staining of control molar sections showing that all molars have vital pulp tissues with 
no obvious inflammation. Red arrows show bone marrow cavity. (B): The inflammation is apparent in right 1st molars’ sections 3 
days after pulp exposure stained by CatK followed by H&E. The inflammation is apparent in sh3bp2KI/KI samples.  
 
Sh3bp2+/+ Sh3bp2+/KI Sh3bp2KI/KI
A 
B 
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In sh3bp2KI/KI mice, the necrosis process of dental pulp seemed to occur at day 3 after the 
coronal opening, whereas more dental pulp remained vital in sh3bp2+/+ mice. The disease 
progressed more rapidly in sh3bp2KI/KI mice than sh3bp2+/KI and sh3bp2+/+ mice. The apical area 
showed severely bone resorption and presence of osteoclasts on the alveolar bone, with generalized 
edema and scattered inflammatory cells in sh3bp2KI/KI mice (Figure 12A). Inflammatory cell 
infiltration significantly increased in the periapical tissues of sh3bp2KI/KI mice, while normal 
periapical tissue was observed in sh3bp2+/+ mice (Figure 12B). 
 
 
 
 
 
 
 
 
 46 
 
 
 
Figure 12. Representative magnified images of pulpal tissues (A) and periapical tissues (B) after 3 days pulp exposure in sh3bp2+/+ 
and sh3bp2KI/KI 
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At 14 days of pulp exposure, evident necrosis of the entire pulp tissue and a variable 
amount of necrotic pulp rests were found in the root canals in all groups (Figure 13A). Moreover, 
the apical cementum surface was irregular and presented resorption lacunae either empty or with 
necrotic pulp rests. Expansion of the mandibles with root resorption and increased CatK(+) cells 
were observed in sh3bp2KI/KI mice. CatK(+) osteoclasts were found on the surface of resorbed 
roots (Figure 14). This result is interesting because root resorption is one of typical features of 
CBM patients.  
 
  
 
 
 
 
 
 
 
Figure 13. Expansion of the mandible with root resorption and increased Cat-K+ cells in sh3bp2KI/KI mice. 
Sh3bp2+/+	 Sh3bp2KI/KI	Sh3bp2+/KI	
Root	resorption	
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Regarding periapical inflammation, inflammatory cells were confined in the periapical area 
in sh3bp2+/+ mice, whereas sh3bp2KI/KI mice showed spreading and increased inflammatory cells 
and bone resorption with no boundary (Figure 15A). Significant loss of furcal bone with increased 
CatK(+) cells were also observed in furcation area of sh3bp2KI/KI mice compared to the sh3bp2+/+ 
mice (Figure 15B). 
Figure 14. CatK(+) osteoclasts were found on the surface of resorbed roots in sh3bp2KI/KI mice 
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Figure 15. Periapical area (A) and furcation (B) of in sh3bp2+/+ and sh3bp2KI/KI 14 days after pulp exposure  
Sh3bp2+/+ (day 14) Sh3bp2KI/KI (day 14)
A 
B 
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Quantitative analysis of osteoclast numbers 
 
Data related to the ratio of CatK(+) area/bone perimeter and number of CatK(+) cells are 
presented in Figure 16A and B. sh3bp2KI/KI mice showed higher percentage of CatK(+) area/ bone 
perimeter on days 7 and 14 compared to other groups (Figure 16A). Also, sh3bp2KI/KI mice showed 
higher percentage of CatK(+) numbers on days 7 and 14 compared to other groups (Figure 16B).  
 
 
 
 
 
 
 
 
 
 
  
Figure 16. Distribution of CatK(+) in the periapical area over time: (A) Ratio of CatK area per bone perimeter around the 
periapical of the mandibular first molar after pulp exposure (B): Number of CatK(+) cells around the periapical of the 
mandibular first molar after pulp exposure. 
A 
B 
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Chapter V: Discussion  
 
CBM causes increased inflammatory bone loss in jawbones leading to premature 
exfoliation of the primary and permanent dentition (15). In heathy bone tissue, the mineralized 
bone is removed by osteoclasts followed by the formation of bone matrix from the osteoblasts that 
subsequently become mineralized. The remodeling cycle consists of three phases: i) resorption 
(osteoclasts digest old bone); ii) reversal (mononuclear cells appear on the bone surface); and iii) 
formation (osteoblasts lay down new bone and the resorbed bone is replaced) (188). In the jaw, 
this process serves to adjust the alveolar bone architecture to meet the mechanical needs and to 
repair damages. Local bone remodeling involves different mediators such as cytokines and growth 
factors (145, 188). The RANK, RANKL, and OPG play important roles in the regulation of bone 
resorption and formation (188). In milder CBM cases, enlargement of the jaw continues throughout 
childhood and stabilizes during puberty, and the abnormal growths are gradually replaced with 
normal bone in early adulthood. Cytokines and the hypersensitivity of myeloid cells trigger a self-
sustaining loop of TNF-α expression that leads to osteoclastogenesis and soft fibrous tissue 
formation (4). In this study, we tested the hypotheses that AP may exacerbate host inflammatory 
response in CBM mice. The results show that dental pulp exposure resulted in AP as early as at 
day 3 in sh3bp2KI/KI mice and continuous weight loss over time. Moreover, inflammatory bone 
resorption was more severe in sh3bp2KI/KI mice.  
It has been suggested that SH3BP2 is a positive regulatory adaptor of inflammatory cells 
(T cells, B cells, and NK cells) that produce factors that induce osteoclastic differentiation and 
promote inflammation (189, 190). Ueki et al., reported that in vivo phenotypes (i.e. loss of alveolar 
and cortical bone, inflammatory tissue infiltration, and lymph node abnormalities) was more 
severe in homozygous CBM mice in comparison to heterozygous littermates (4). This difference 
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is in part due to increased expression of serum TNF-α which was only increased in homozygous 
mutants. TNF-α is known to induce RANKL expression and stimulates formation of osteoclast 
progenitors (4, 191). Also, TNF-α gene promoter is known to contain several NF-κB-like motifs 
that play a prominent role in TNF-α transcription in primary macrophages (192). The effects of 
TNF-α in sh3bp2KI/KI are consistent with that of inflammatory bone loss in humans and mice. In 
this study, sh3bp2KI/KI mice with pulp exposure showed more weight loss than those without pulp 
exposure (Figure 7). Although naïve sh3bp2KI/KI mice start to loose weight after ages of 10 weeks, 
the initial weight loss (14 days after pulp exposure) is a result of dental infection. Whether TNF-α 
is further increased by dental infection which subsequently leads to more bone and body weight 
loss still need further investigations.  
In this study, radiographs of mandibles showed noticeable periapical radiolucency in the 
sh3bp2KI/KI mice after 3 days of pulp exposure.  Similar results were reported in studies using 
different animal models (139, 143, 144). The onset of CBM in human is between 2-5 year-old.  
CBM results in premature tooth exfoliation, jawbone loss, soft tissue inflammation and swelling. 
In this study, at 14 days of pulp exposure, we observed the most extensive inflammatory responses 
with root resorption and increased CatK-(+) cells in sh3bp2KI/KI mice and not in the control 
sh3bp2KI/KI mice (Figure 13).   This result suggests that AP accelerates the progression of CBM. 
Progression of the periapical lesion is related to two events: 1) production of the pro-inflammatory 
cytokines, such as IL-1, IL-6, and TNF-α; 2) cellular migration and osteoclast differentiation. Our 
study points out that osteoclasts were associated with the resorption areas in the periapical regions 
as well as surfaces of resorbed roots of the CBM mice. We observed the mean number of 
osteoclasts from sh3bp2+/+ mice had a progressive and significant increase over 21 days after pulp 
exposure. This result was similar to a previous publication that showed progressive increase of 
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osteoclast numbers at 7, 21, and 42 days after pulp exposure (161). The authors also suggested that 
cementocytes expressing RANKL, but not osteocytes, may also be involved in the modulation of 
AP. In addition, bacterial products such as LPS stimulate IL-1β and TNF-α production, thereby 
inducing osteoclast activity (193). Kawashima and Stashenko determined the kinetics of 
expression of bone resorption and regulatory cytokines in a mouse model of AP (145). They 
showed that there is a clear relationship between the expression of IL-1α mRNA and protein and 
periapical bone resorption. A significant large amount of IL-1α production was observed at 7 days 
after pulp exposure. TNF-α mRNA and protein also significantly increased in response to pulpal 
infection. The correlation between TNF-α and IL-1α may be related to their co-stimulatory effects. 
According to the authors, TNF-α may promote bone destruction indirectly through the induction 
of IL-1α, and adjacent bone cells constitutively produce TNF-α which is involved in normal bone 
homeostasis diffusing into the lesion (145). Moreover, they observed that IL-6, IL-2, IL-12, IFN-
γ, IL-4 and IL-10 protein levels increased after pulp exposure, but no IL-6 mRNA was detected. 
This result was explained by the fact that IL-6 may have an extremely short half-life and may be 
difficult to amplify by PCR, or IL-6 protein may not have been produced within the periapical 
lesion but likely due to blood circulation. IL-12 may be produced by T-lymphocyte and IL-12 by 
macrophages and Th1 cells inducing production of IFN-γ. IFN-γ seems to have contradictory 
effects on bone resorption activity. It activates macrophages to produce cytokines such as IL-1 and 
TNF-α, but also inhibits osteoclast formation, development and function (145). IL-4 and IL-10 are 
Th2-type cytokines that inhibit cytokine production from activated T cells and macrophages. 
Therefore, inflammatory bone resorption may be upregulated in vivo by Th1-type mediators, and 
downregulated by Th2-type mediators (145). We speculate that bacterial products in the periapical 
region of sh3bp2KI/KI mice might increase the inflammatory response, leading to the production of 
 54 
higher levels of TNF-α activating the osteoclasts. Future studies need to be performed to confirm 
the role of cytokines after induction of AP in CBM mice. 
Our results also show that there is a positive correlation between CatK(+)-cell number and 
inflammation in sh3bp2KI/KI mice. CatK is a lysosomal cysteine protease that is highly expressed 
in osteoclasts and has been implicated in the pathogenesis of osteoporosis and other bone diseases 
(194). Due to its high matrix-degrading activity, CatK(+) cells are characterized by an enhanced 
specific proteolytic capability (195). CatK has been shown to have functions in both osteoclasts 
and immune cells, such as macrophages and dendritic cells (196, 197). Patients with endodontic 
disease suffer from both inflammation-induced tissue damage and bone loss (96). Inhibition of 
Catk using the specific small-molecule odanacatib (ODN) by oral administration in a periapical 
lesion mouse model reduced bone resorption by inhibition of the osteoclast function (activation 
and differentiation) and inflammation simultaneously (7). Gao et al.,  found that osteoclast 
function was impaired and bone resorption was reduced significantly by applying gene therapeutic 
approach to knockdown of CatK gene expression in periapical tissue in a mouse model. CatK 
knockdown gene therapy may significantly reduce the severity of endodontic disease providing a 
novel approach for the pathogenesis and intervention of endodontic and periapical diseases (198). 
So far, there is no reports on how AP develops in CBM mice. However, animal studies 
have shown that AP is induced by inflammation and destruction of periapical tissues. For instance, 
it was demonstrated that MMP-9 KO and TLR2 KO animals developed larger periapical lesions 
with greater inflammatory response, indicating important roles of MMP-9 and TLR2 in the host's 
immune and inflammatory response to root canal and peri-radicular infection (185, 199). A recent 
study on TLR2 KO mice showed a reduction of MMP2 expression and an increase of MMP9 
expression in the final stage of AP (200). Wu et al., showed that 5-LO deficiency impaired the host 
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innate immune system and aggravated AP in an experimental murine AP model (201). 5-LO 
mediates RANKL-induced osteoclast formation and plays protective roles in the immune response. 
Zhang et al. reported that AP elevated the levels of cytokines in rat blood serum, causing reversible 
changes in the aortic arch, myocardium, and spleen as well as irreversible changes in the liver 
(151).  
Analyses of feeding behavior and weight gain appear to be correlated with the degree of 
tooth injury. Pulp exposure injuries resulted in delayed resumption of normal weight in rats (202). 
Diabetic animals were more susceptible to significant weight loss, morbidity and mortality after 
induction of periapical lesions (203). Chundler and Byers showed that tooth injuries result in 
behavioral changes similar to other pain models such as yawning, reduced body weight gain and 
decreased time spent. They also showed that weight recovered by day three in rats with two teeth 
injuries but remained low in those rats with three to four teeth injuries (204). Our study shows that 
while sh3bp2+/+ and sh3bp2+/KI mice recovered after initial weight loss at 7 days, sh3bp2KI/KI mice 
continued to lose weight after pulp exposure for 21 days. This data suggest that sh3bp2KI/KI mice 
may suffer from more pain associated with tooth injury in comparison to their sh3bp2+/+ and 
sh3bp2+/KI littermates. It is still unknown whether sh3bp2KI/KI mice develop SAP. However, it is 
possible that these mice have increased inflammatory pain due to their continuous weight loss, as 
weight loss is considered an index of pain in mice with tooth injuries (202, 204). There is 
considerable evidence in humans that weight loss occurs in association with dental injury (205, 
206). Importantly, it has been shown that after dental interventions to treat caries and alleviate pain 
and infection, children quickly recover their weight and achieve normal growth (207, 208). One 
hypothesis is that patient with dental pain has difficulty to eat (209).  
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More studies are needed such as examining the gene or proteomic profiles of apical 
periodontitis to evaluate whether any pain–related marker genes are differentially regulated in 
sh3bp2KI/KI mice. The correlation of these cytokines in addition to the pain-related pain marker 
might lead to the development of SAP in a mouse model. 
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Chapter VI: Conclusion and future directions 
 
We concluded that sh3bp2KI/KI mice developed larger periapical lesions with a greater 
number of CatK(+) osteoclasts compared with the sh3bp2+/+ animals, indicating the important 
effect of SH3BP2 during the immune and inflammatory response against the infection of root canal 
system and periapical tissues. Also, AP exacerbate host inflammatory response in CBM mice. 
Based on this study, we suggest that dentists should close monitor CBM patients to prevent AP. 
Future studies will elucidate role of inflammatory cells such as neutrophils, expression of 
cytokines, pain–related marker genes and proteomic profiles to determine the mechanism that 
regulates AP in sh3bp2KI/KI mice. 
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